| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.461 | 35.322 | 35.726 | 22.749 | 30.649 | 22.607 | 15.194 | 25.514 | 34.196 | 25.056 |
| Total Income - EUR | 31.461 | 35.322 | 35.726 | 22.749 | 30.649 | 22.607 | 15.194 | 25.514 | 34.196 | 25.056 |
| Total Expenses - EUR | 29.409 | 31.094 | 27.464 | 22.247 | 25.164 | 19.948 | 10.895 | 23.842 | 27.242 | 33.354 |
| Gross Profit/Loss - EUR | 2.052 | 4.228 | 8.262 | 502 | 5.485 | 2.659 | 4.299 | 1.672 | 6.954 | -8.299 |
| Net Profit/Loss - EUR | 1.108 | 3.522 | 7.911 | 274 | 5.179 | 2.379 | 4.153 | 1.450 | 6.629 | -8.550 |
| Employees | 2 | 0 | 2 | 2 | 0 | 0 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Medo Optisan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.631 | 2.904 | 2.728 | 2.678 | 1.686 | 1.666 | 1.631 | 3.241 | 3.016 | 2.784 |
| Current Assets | 14.342 | 19.720 | 27.888 | 18.155 | 22.732 | 20.705 | 22.521 | 21.155 | 27.699 | 19.291 |
| Inventories | 10.209 | 10.584 | 16.383 | 13.581 | 14.161 | 12.890 | 17.131 | 16.826 | 21.666 | 16.176 |
| Receivables | 0 | 786 | 306 | 291 | 0 | 0 | 312 | 759 | 748 | 766 |
| Cash | 4.132 | 8.350 | 11.199 | 4.283 | 8.571 | 7.815 | 5.078 | 3.571 | 5.284 | 2.350 |
| Shareholders Funds | 1.162 | 3.575 | 7.964 | 326 | 5.229 | 2.428 | 6.527 | 7.728 | 12.888 | 3.305 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.811 | 19.049 | 22.652 | 20.936 | 19.189 | 19.943 | 17.625 | 16.669 | 17.827 | 18.770 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Medo Optisan Srl